Merck & Company, Inc. Common Stock (new) (MRK)
Merck & Company, Inc. Common Stock (new) (MRK) Company Bio
Merck & Company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. The company was founded in 1891 and is based in Kenilworth, New Jersey.
MRK Stock Chart More Charts
MRK Price/Volume Stats
| Current price | $75.87 |
| Prev. close | $75.60 |
| Day low | $75.47 |
| Day high | $76.32 |
| 50-day MA | $75.57 |
| 200-day MA | $67.33 |
| 52-week high | $80.19 |
| 52-week low | $52.83 |
| Volume | 14,294,500 |
| Avg. volume | 13,828,400 |
| Dividend yield | 2.91% |
| Market Cap | 204.56B |
MRK Returns
| 1-mo | 4.07% |
| 3-mo | 5.28% |
| 6-mo | 21.29% |
| 1-year | 27.60% |
| 3-year | 63.39% |
| 5-year | 70.94% |
| YTD | -0.71% |
| 2018 | 39.95% |
| 2017 | -1.49% |
| 2016 | 15.05% |
| 2015 | -3.89% |
| 2014 | 16.93% |
MRK Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...